Alembic Pharmaceuticals Limited (APLLTD.NS)
INR 1045.0
(-1.06%)
INR 1045.0
(-1.06%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 26.78 Billion INR | -29.14% |
| 2022 | 39.43 Billion INR | 12.4% |
| 2021 | 35.08 Billion INR | -6.56% |
| 2020 | 37.54 Billion INR | 18.16% |
| 2019 | 31.77 Billion INR | 21.61% |
| 2018 | 26.13 Billion INR | 32.46% |
| 2017 | 19.72 Billion INR | -1.0% |
| 2016 | 19.92 Billion INR | -9.93% |
| 2015 | 22.12 Billion INR | 76.75% |
| 2014 | 12.51 Billion INR | 17.98% |
| 2013 | 10.6 Billion INR | 36.63% |
| 2012 | 7.76 Billion INR | 2.38% |
| 2011 | 7.58 Billion INR | 38.75% |
| 2010 | 5.46 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 7.18 Billion INR | 7.89% |
| 2023 Q2 | 11.33 Billion INR | 5.67% |
| 2023 Q1 | 10.72 Billion INR | 10.13% |
| 2023 FY | 27.94 Billion INR | -29.14% |
| 2023 Q3 | 11.69 Billion INR | 3.2% |
| 2023 Q4 | 6.66 Billion INR | -43.04% |
| 2022 Q1 | 8.83 Billion INR | 30.14% |
| 2022 Q3 | 10.54 Billion INR | 2.13% |
| 2022 Q4 | 9.73 Billion INR | -7.6% |
| 2022 FY | 39.43 Billion INR | 12.4% |
| 2022 Q2 | 10.31 Billion INR | 16.76% |
| 2021 Q1 | 9.4 Billion INR | 60.87% |
| 2021 Q2 | 9.59 Billion INR | 1.96% |
| 2021 Q3 | 9.29 Billion INR | -3.17% |
| 2021 Q4 | 6.79 Billion INR | -26.89% |
| 2021 FY | 35.08 Billion INR | -6.56% |
| 2020 FY | 37.54 Billion INR | 18.16% |
| 2020 Q2 | 11.45 Billion INR | 14.11% |
| 2020 Q4 | 5.84 Billion INR | -42.73% |
| 2020 Q1 | 10.03 Billion INR | 81.0% |
| 2020 Q3 | 10.21 Billion INR | -10.81% |
| 2019 Q2 | 9.68 Billion INR | 30.05% |
| 2019 Q3 | 9.1 Billion INR | -5.95% |
| 2019 Q4 | 5.54 Billion INR | -39.12% |
| 2019 FY | 31.77 Billion INR | 21.61% |
| 2019 Q1 | 7.44 Billion INR | 95.18% |
| 2018 Q1 | 6.07 Billion INR | 2.98% |
| 2018 Q2 | 8.55 Billion INR | 40.84% |
| 2018 Q4 | 3.81 Billion INR | -50.44% |
| 2018 Q3 | 7.69 Billion INR | -9.98% |
| 2018 FY | 26.13 Billion INR | 32.46% |
| 2017 Q3 | 6.13 Billion INR | 6.53% |
| 2017 FY | 19.72 Billion INR | -1.0% |
| 2017 Q4 | 5.89 Billion INR | -3.92% |
| 2017 Q2 | 5.75 Billion INR | 23.55% |
| 2017 Q1 | 4.66 Billion INR | -13.06% |
| 2016 FY | 19.92 Billion INR | -9.93% |
| 2016 Q1 | 5.36 Billion INR | 9.03% |
| 2016 Q2 | 6.31 Billion INR | 17.85% |
| 2016 Q3 | 5.64 Billion INR | -10.64% |
| 2016 Q4 | 5.36 Billion INR | -5.01% |
| 2015 Q4 | 4.91 Billion INR | -31.24% |
| 2015 Q3 | 7.14 Billion INR | -8.52% |
| 2015 Q2 | 7.81 Billion INR | 111.61% |
| 2015 Q1 | 3.69 Billion INR | 48.42% |
| 2015 FY | 22.12 Billion INR | 76.75% |
| 2014 Q3 | 3.32 Billion INR | -6.48% |
| 2014 Q2 | 3.55 Billion INR | 12.76% |
| 2014 Q1 | 3.15 Billion INR | 54.23% |
| 2014 FY | 12.51 Billion INR | 17.98% |
| 2014 Q4 | 2.48 Billion INR | -25.13% |
| 2013 FY | 10.6 Billion INR | 36.63% |
| 2013 Q4 | 2.04 Billion INR | -33.85% |
| 2013 Q1 | 2.53 Billion INR | 70.32% |
| 2013 Q3 | 3.08 Billion INR | 4.96% |
| 2013 Q2 | 2.94 Billion INR | 16.16% |
| 2012 Q4 | 1.48 Billion INR | -32.75% |
| 2012 Q1 | 1.9 Billion INR | 0.0% |
| 2012 FY | 7.76 Billion INR | 2.38% |
| 2012 Q2 | 2.16 Billion INR | 13.41% |
| 2012 Q3 | 2.21 Billion INR | 2.37% |
| 2011 FY | 7.58 Billion INR | 38.75% |
| 2010 FY | 5.46 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | -1237.508% |
| Ind-Swift Limited | 2.17 Billion INR | -1132.696% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -1719.581% |
| Sakar Healthcare Limited | 699.58 Million INR | -3728.084% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 75.552% |
| Innova Captab Limited | 3.46 Billion INR | -673.017% |
| Divi's Laboratories Limited | 32.44 Billion INR | 17.445% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -330.371% |
| Morepen Laboratories Limited | 6.16 Billion INR | -334.661% |
| Mankind Pharma Limited | 42.19 Billion INR | 36.534% |
| Sequent Scientific Limited | 2.97 Billion INR | -799.064% |
| Wanbury Limited | 1.73 Billion INR | -1447.442% |
| Laurus Labs Limited | 15.44 Billion INR | -73.352% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -455.237% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -115.4% |
| Alembic Limited | 1 Billion INR | -2577.783% |
| Hikal Limited | 5.95 Billion INR | -349.491% |
| Neuland Laboratories Limited | 8.24 Billion INR | -224.7% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -75.509% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 61.378% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -467.496% |
| Themis Medicare Limited | 2.42 Billion INR | -1006.637% |
| RPG Life Sciences Limited | 2.48 Billion INR | -978.562% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 78.612% |
| Lupin Limited | 125.09 Billion INR | 78.592% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -1178.903% |
| Wockhardt Limited | 7.72 Billion INR | -246.9% |
| Vaishali Pharma Limited | 90.32 Million INR | -29549.923% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -359.254% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -4003.756% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -36.337% |
| FDC Limited | 6.58 Billion INR | -306.618% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 83.631% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -4216.147% |
| Eris Lifesciences Limited | 10.42 Billion INR | -156.845% |
| Venus Remedies Limited | 2.18 Billion INR | -1127.018% |
| ZIM Laboratories Limited | 1.26 Billion INR | -2012.354% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -624.697% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -4961.213% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -190.889% |
| Shilpa Medicare Limited | 3.56 Billion INR | -651.866% |
| Albert David Limited | 1.4 Billion INR | -1801.921% |
| Ajanta Pharma Limited | 21.06 Billion INR | -27.14% |
| Hester Biosciences Limited | 1.27 Billion INR | -2002.673% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -549.501% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 1717.29% |
| Gufic Biosciences Limited | 4.07 Billion INR | -557.399% |
| Windlas Biotech Limited | 1.33 Billion INR | -1900.351% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -363.222% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -23593.654% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -3774.562% |
| Granules India Limited | 16.79 Billion INR | -59.416% |
| Aarti Drugs Limited | 8.31 Billion INR | -222.03% |
| Bal Pharma Limited | 770.19 Million INR | -3377.132% |
| Alkem Laboratories Limited | 52.29 Billion INR | 48.791% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 89.639% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -1319.322% |
| Medicamen Biotech Limited | 495.49 Million INR | -5304.838% |
| Unichem Laboratories Limited | 4.86 Billion INR | -450.485% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -5822.929% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -213377.083% |
| Valiant Laboratories Limited | 138.02 Million INR | -19302.227% |
| Orchid Pharma Limited | 2.32 Billion INR | -1054.19% |
| Medico Remedies Limited | 262.14 Million INR | -10116.026% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -547.938% |
| Ipca Laboratories Limited | 48.58 Billion INR | 44.878% |
| Brooks Laboratories Limited | 65.62 Million INR | -40711.795% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -4686.516% |
| Piramal Enterprises Limited | 8.04 Billion INR | -232.957% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 42.724% |
| NATCO Pharma Limited | 25.73 Billion INR | -4.059% |
| Suven Life Sciences Limited | -200.79 Million INR | 13437.201% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 24726.61% |
| Strides Pharma Science Limited | 14.38 Billion INR | -86.131% |
| Indoco Remedies Limited | 8.04 Billion INR | -232.969% |
| Alpa Laboratories Limited | 188.89 Million INR | -14077.559% |
| Lasa Supergenerics Limited | 121.02 Million INR | -22027.324% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -6748.128% |